Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraham Raz

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Journal of Bioenergetics and Biomembranes|February 24, 2007
Galectin-3 in apoptosis, a novel therapeutic targetPratima Nangia-Makker, Susumu Nakahara, Victor Hogan, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Biomolecules|February 25, 2022
The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?Lucas de Freitas Pedrosa, Avraham Raz, João Paulo Fabi
Biochemical and Biophysical Research Communications|April 2, 2013
Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic traffickingTatsuyoshi Funasaka, Vitaly Balan, Avraham Raz, et al.
Cancer Research|August 17, 2005
Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cellsRuby Shalom-Feuerstein, Tomer Cooks, Avraham Raz, et al.
Cancer Research|August 26, 2017
Cancer Self-Defense: An Immune StealthKosei Nakajima, Pratima Nangia-Makker, Victor Hogan, et al.
Cancer Research|January 9, 2003
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblastsSoichi Tsutsumi, Victor Hogan, Ivan R Nabi, et al.
Trends in Molecular Medicine|April 3, 2002
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agentsPratima Nangia-Makker, Jeffrey Conklin, Victor Hogan, et al.
International Journal of Cancer|October 21, 2003
Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expressionArayo Haga, Tatsuyoshi Funasaka, Yasufumi Niinaka, et al.
Cancer Research|May 8, 2007
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cellsTatsuyoshi Funasaka, Huankai Hu, Takashi Yanagawa, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Journal of Bioenergetics and Biomembranes|February 24, 2007
Galectin-3 in apoptosis, a novel therapeutic targetPratima Nangia-Makker, Susumu Nakahara, Victor Hogan, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Biomolecules|February 25, 2022
The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?Lucas de Freitas Pedrosa, Avraham Raz, João Paulo Fabi
Biochemical and Biophysical Research Communications|April 2, 2013
Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic traffickingTatsuyoshi Funasaka, Vitaly Balan, Avraham Raz, et al.
Cancer Research|August 17, 2005
Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cellsRuby Shalom-Feuerstein, Tomer Cooks, Avraham Raz, et al.
Cancer Research|August 26, 2017
Cancer Self-Defense: An Immune StealthKosei Nakajima, Pratima Nangia-Makker, Victor Hogan, et al.
Cancer Research|January 9, 2003
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblastsSoichi Tsutsumi, Victor Hogan, Ivan R Nabi, et al.
Trends in Molecular Medicine|April 3, 2002
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agentsPratima Nangia-Makker, Jeffrey Conklin, Victor Hogan, et al.
International Journal of Cancer|October 21, 2003
Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expressionArayo Haga, Tatsuyoshi Funasaka, Yasufumi Niinaka, et al.
Cancer Research|May 8, 2007
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cellsTatsuyoshi Funasaka, Huankai Hu, Takashi Yanagawa, et al.
Pageof 13